1. Kawabata Y, Hirokawa M, Saitoh Y, et al. Late-onset fatal Epstein-Barr virus-associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia. Int J Hematol. 2006;84:445-448.
2. Kawa K. Hemophagocytic syndrome-treatment strategies according to classification and scoring system. In: Education Program Book of the 67th Annual Meeting of the Japanese Society of Hematology and the 47th Annual Meeting of the Japanese Society of Clinical Hematology. Tokyo, Japan; 2005:72-75.
3. Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998;92:1549-1555.
4. Ohga S, Kanaya Y, Maki H, et al. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia. Bone Marrow Transplant. 2000;25:209-212.
5. Cohen J, Gandhi M, Naik P, et al. Increased incident of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. Br J Haematol. 2005;129:229-239.